Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Nov 11;16(11):e0259376. doi: 10.1371/journal.pone.0259376

Exploring the awareness, attitudes, and actions (AAA) of UK adults at high risk of severe illness from COVID-19

Stuart W Flint 1,2, Adrian Brown 3,4,*, George Sanders 5, Abd A Tahrani 6,7,8
Editor: Christophe Leroyer9
PMCID: PMC8584659  PMID: 34762659

Abstract

Background

People at high risk of severe illness from COVID-19 have experienced greater restrictions during the pandemic, yet there is a paucity of research exploring their lived experience.

Objectives

This study explored the impact of COVID-19 on people identified as at high risk of severe illness by UK Government, and in particular, the impact of the first lockdown on access to healthcare, medications and use of technological platforms.

Methods

1038 UK adults who identified as at high risk of severe illness from COVID-19 in line with UK Government guidance or self-identified with acute or other chronic health conditions, completed the Awareness, Attitudes and Actions survey which explored the impact of COVID-19 on access to healthcare, management of long-term health condition, mental health, and health behaviours.

Results

Most participants reported feelings of vulnerability, anxiety and isolation, noticed that other people changed their behaviour towards them including a feeling of being stigmatised by people not categorised as high risk. Participants described the largely negative impact that the COVID-19 lockdown had on to health-related behaviours and access to healthcare, which had resulted in large declines in mental health and wellbeing. Participants also indicated disappointment at the UK Governments response and handling of the COVID-19 lockdown.

Implications

This study provides novel evidence of the lived experience of the first COVID-19 lockdown for people identified as at high risk of severe illness. In the context of behavioural health interventions, the ubiquity of digital technologies and their adoption into day-to-day life translates into greater potential reach than traditional interventions, and consequently, greater potential for positive public health impact. Findings should be considered by policymakers and healthcare professionals to support people now and as we transition through the recovery phase with a particular emphasis on supporting mental health and changes to the management of long-term health conditions.

Introduction

On 23 March 2020, the UK Government enacted measures that were included in the Coronavirus Act 2020 and recommended that everyone, except in certain essential circumstances, must stay in their homes [1]. Consequently, many of the elements enabling and supporting face-to-face access and healthcare became impossible to deliver due to the pandemic lockdown. In order to continue with everyday life, those identified as high risk had to self-isolate, shield and often adapt to solely digital or telephone solutions.

In addition to the population restrictions, it was recommended that people who were identified as at high risk of severe illness from COVID-19 follow greater restrictions compared to people without a high risk status; high risk status was based on an existing chronic health condition such as coronary heart disease, chronic kidney disease and diabetes, aged 70 years or above and if a person was pregnant [2]. With research demonstrating that people who were identified as at high risk were disproportionately impacted, and as countries across the world reduce restrictions such as national or regional lockdowns, there is a need to understand and appropriately respond to the experiences and changes that have occurred as a result. Gaining this knowledge should support changes that will need to be made to provide support for people who have been disproportionately impacted, and where relevant, to support the development and design of future care systems which have evolved during the pandemic such as the increased use of technology and changes to the way that people have accessed medications and healthcare.

Empirical research has demonstrated that despite concerns about infection of COVID-19, there is a lack of knowledge, use of risk mitigating behaviours or change to people’s typical routines including amongst high risk groups [3, 4]. Furthermore, data published last year from our group identified that access to healthcare, health-related behaviours and psychological wellbeing of people at higher risk of severe illness from COVID-19 were negatively impacted [4]. This previous data demonstrates a quantified negative impact that people in high risk groups experienced during the first COVID-19 lockdown, however, there continues to be a dearth of qualitative research that explores the lived experience and provides in-depth accounts of the impact of the first COVID-19 lockdown.

The current study presents time-sensitive findings about the lived experience of people in high risk groups during the first COVID_19 lockdown in the UK, and in doing so, offers insights that can support the development or modification of existing care pathways, provision and policy in the UK.

Methods

Design

The Awareness, Attitudes and Action (AAA) survey was developed to explore the impact, including the lived experiences, of the COVID-19 pandemic and associated restrictions such as the national lockdown, on people identified as at high risk or self-identifying as at high-risk due to an acute or chronic condition not listed by UK Government; for further details of the AAA survey, please see Flint et al. 2020 [4]. The online survey was completed by 1026 UK adults aged 18 years or above who were recruited using pragmatic sampling [5] through a variety of advertisements disseminated by health charities, public and patient organisations, and on social media; for a breakdown of participant demographics, please see Flint et al. [4]. All participants provided informed consent before taking part in the study.

The AAA survey has 7 sections using both open-ended and closed questions. In our previous publication [4], we presented the findings of the closed questions which were analysed using statistical modelling and Behavioural Artificial Intelligence, and are published separately to the current study’s findings [4].

The current study presents the analysis of the 17 qualitative, open-ended questions from the AAA survey. An example question was: “Describe how being identified as being at a higher risk of severe illness from coronavirus (COVID-19) by the UK Government, has made you feel?; see S1 File for an overview of the open-ended survey questions. Consequently, questions demonstrated aspects of face validity, as they were transparent and relevant to the priority population [6]. Objectivity was maintained by the principal investigator as the resultant qualitative data aligned to the methodological framework for combining quantitative and qualitative survey methods [7], which was fit to serve as evidence for satisfying the research question [8]. Given the aim and objectives of this study, the Evidence Integration Triangle [9] was adopted as the overarching theoretical framework. Through the prompt identification of barriers and facilitators of reasons exploring AAA of UK adults at high risk of severe illness from COVID-19, the framework allows for the exploration of the three main evidence-based components of program/policy, implementation processes and measures of progress. Adoption of such an integrated framework allows for more consistent mapping, evaluation and incorporation of successful methods and strategies for modifying behavioural determinants [10].

We defined impact as changes that occurred as a consequence of restrictions to reduce COVID-19 transmission e.g., shielding, to different aspects of everyday life, including actions and attitudes, healthcare delivery, mental health and well-being, health-related lifestyle behaviours and social interaction.

Institutional ethical approval was received from the School of Psychology Research Ethics Committee at University of Leeds (REC number PSYC-28). All data were anonymised, and survey responses coded throughout to ensure confidentiality.

Data coding and analysis

The pen profile approach presents findings from content analysis via a diagram of composite key emerging themes [11]. In summary, deductive content analysis was initially adopted to categorise survey data into four a priori pen profiles including i) awareness, ii) attitudes and concerns, iii) actions, and iv) changes. Inductive analysis then allowed emergent themes to be retrospectively applied into one of the four a priori pen profiles where relevant, with n representing individual ‘mentions’ per participant; multiple ‘mentions’ by the same participant were only counted once. Data were then organised schematically to assist with interpretation of the themes [12]. Verbatim quotations were subsequently used to expand the pen profiles, provide context, and verify participant responses. Quotations were labelled by participant number (Pn). Methodological rigour was demonstrated through a process of triangular consensus between members of the research team. This offered transparency, credibility and trustworthiness of the results, as the data were critically reviewed using a reverse tracking process from the pen profiles back to the verbatim transcripts, providing alternative interpretations of the data. All investigators were in agreement with the initial interpretation of results made by the principal investigator.

Results

The pen profiles and associated emergent themes are presented in Figs 14, respectively. Table 1 presents the emergent themes and frequency of mentions across the high risk groupings.

Fig 1. Exploring the awareness of UK adults at high risk of severe illness during the COVID-19 lockdown.

Fig 1

Fig 4. Exploring the changes of UK adults at high risk of severe illness during the COVID-19 lockdown.

Fig 4

Table 1. Emergent themes: Frequency of mentions across high risk sub-groups.

 Theme Frequency of sub-group mentions (Yes:No), unless otherwise stated.
Diabetes (N = 538) BMI ≥ 40 kg/m2 (N = 142) Chronic Respiratory Disease (N = 179) Chronic Heart Disease (N = 132)  Chronic Kidney Disease (N = 147) Chronic Liver Disease (N = 49)  Chronic Neurological Disease (N = 35)  Spleen Problems (N = 16) Weakened Immune System (N = 159) Aged > 70 years (N = 178) Pregnant (N = 21)  Other Risk Factors (N = 303)
Awareness                         
Agree with high risk categorisation 146:25  35:9 46:14 35:11 40:18 18:12 17:9 5:4 24:89 53:45 10:11 87:39
Sufficient restriction information 151:44  73:21 71:11 64:13 53:12 14:6 11:8 3:0 19:2 131:34 5:7 204:25
Sufficient impact information 102:90  41:12 72:17 52:21 40:19 14:6 11:4 7:0 86:22 44:57 8:5 39:33
Attitudes & Concerns 
Behave differently towards you 69:6  74:9 35:0 27:0 17:0 15:5 0:3 8:0 44:0 86:3 14:0 27:0
Stigmatisation 65:42  25:19 21:17 4:12 0:11 0:0 0:0 0:8 24:0 37:13 5:0 44:36
Peer Support 18:4  23:6 8:3 21:1 22:0 9:1 14:0 0:1 31:4 55:19 11:7 24:28
High risk categorisation feelings (+ve:-ve) 20:262  25:105 18:14 13:49 15:23 7:14 0:19 0:11 19:77 57:104 5:13 20:118
Actions 
Social distancing 214:3  56:0 71:0 66:0  53:0 14:0 7:0 0:0 71:0 98:10 9:0 73:4
Self-isolation 87:18  62:24 68:0 54:0 34:0 15:0 21:0 4:0 52:0 102:0 7:6 35:47
Online shopping 124:37  65:22 89:28 36:19 32:25 28:21 18:17 16:0 52:68 96:53 9:5 85:64
Shielding 22:7  25:0 14:4 28:3 17:0 7:12 6:0 11:0 85:12 33:1 2:0 31:10
Changes 
Lifestyle (+ve:-ve) 304:884  77:397 18:141 35:177 24:53 31:95 15:72 8:26 33:103 27:341 7:22 98:487
Healthcare (+ve:-ve) 49:373  23:188 31:107 0:104 22:62 22:59 15:15 0:28 12:141 42:121 0:17 33:92
Online healthcare support (+ve:-ve) 68:11  34:13 29:34 37:8 14:0 18:12 7:14 0:7 45:20 32:39 0:0 61:28
Mental health & wellbeing (+ve:-ve) 12:181  9:104 3:86 4:88 17:61 5:33 3:20 3:7 13:81 22:63 4:4 3:67

Note: +ve, positive -ve, negative.

Awareness

Fig 1 outlines participants’ awareness and shows that the majority felt they had received sufficient information about the restrictions placed on high risk groups during the first lockdown.

I had four letters informing me I was high risk and should shield, three similar letters from hospital consultants and one other from my GP.

There was a mixed response by participants when asked whether they agreed with their high risk group categorisation. Whilst many (64.3%) participants agreed with their high risk status, over a third (35.7%) of participants either disagreed or were unsure. Data suggested that one of the primary reasons for either agreeing or disagreeing was the available evidence to support high risk categorisation. This was further evidenced by participant perceptions about the amount of information they had received about both restrictions for high risk groups and the health impact of contracting COVID-19.

I have always been told that I am at a higher risk of illness from seasonal flu so it is logical to accept, when presented, the higher risk posed to me by COVID-19.

The information on symptoms (from COVID-19) are too general and basic

I think I should be on the shielding list because of my BMI and asthma, but the surgery are going by the government list which doesn’t link medical conditions or include people with high BMI. I am very worried I won’t survive if I get the virus as the asthma nurse told me my weight is affecting my ability to breathe. I am scared I will die

Attitudes and concerns

Fig 2 outlines participants’ attitudes and concerns towards contracting COVID-19. A large majority (94.1%) of respondents noticed people behaving differently towards them, and 58.7% of respondents reported feeling stigmatised. However, the majority (76.1%) received sufficient peer support during the first COVID-19 lockdown.

Fig 2. Exploring the attitudes and concerns of UK adults at high risk of severe illness during the COVID-19 lockdown.

Fig 2

“Kept away physically and stopped communicating by phone or any other medium. There’s more blame, aggression and dismissiveness.”

“The frequency of phone and on-line contact from and to my family has increased.”

Furthermore, participants noted largely negative (80.3%) emotions towards being categorised as high risk with feelings which centred on vulnerability, anxiety, and isolation, which in some instances led to further feelings of stigmatisation. Participants not only commented that they felt vulnerable, but that the high risk status was having an impact on their mental health.

“I live alone and feel very isolated yet nobody has explained anything to me. My family live a long distance away and I am feeling very lonely and sad at not knowing when I may be given some vague timeframe when I can see my daughter and Granddaughters. I think my mental health is suffering very badly.”

Actions

Fig 3 shows that, on the whole, participants adhered to Government recommendations regarding social distancing (97.7%), self-isolation (85.1%) and shielding (85.1%). Although there was a sense of resentment to those not following the recommendations and not taking them seriously, while others felt that everyone should be playing their part in reducing risk.

Fig 3. Exploring the actions of UK adults at high risk of severe illness during the COVID-19 lockdown.

Fig 3

“I am following all the precautionary guidelines so as to not infect anybody and also to keep me and my family safe.”

Participants also noted utilising online shopping methods during the first COVID lockdown to support adherence to such guidelines. However, issues related to online shopping were noted in 35.6% of participant comments, where participants were unable to use online shopping due to a lack of availability, with a feeling that priority should be given to those at highest risk and with chronic diseases.

Our big weekly shop has been online for some time.

“I have tried online (shopping) but can’t get a slot.”

“Determined to try not to get it, but feel those of us in the high risk group have been abandoned by the Government. I have read reports of people in that group still being forced to work by their employer, in high risk roles. Many of us can’t get online shopping slots, even those who have shopped for years online. I’ve seen first-hand stories of disabled people who have paid for carers withdrawn, due to illness, when they can’t physically look after themselves.”

Changes to healthcare and health-related lifestyle behaviours

Fig 4 outlines largely positive (65%) views regarding the switch from face-to-face to online or telephone healthcare support. Contrastingly, negative views were expressed with regards to the changes that the first COVID-19 lockdown caused to health-related lifestyle behaviours (80.5%) (across shopping, diet, alcohol consumption, physical activity, & sleep) and healthcare access (84%) (across appointments, medication, elective surgery, communication platform, & clinician care), as well as mental health and wellbeing (89%).

“Less exercise leading to increased weight. A sense of anxiety about becoming ill. A feeling that if I catch it [COVID-19] I will die as I am of no further use to society. A big fear of not surviving until a vaccine is readily available. A worry that the vaccine may not work fully as it is being produced in a big hurry.”

“I am very concerned about the delay in being scanned [for cancer]. I have worries about the return of the cancer as I wasn’t able to detect anything myself when it was found, therefore, it could be back and I would have no knowledge of it.”

These delays resulted in many participants independently changing the management of their long-term health condition and in some instances, without notifying their healthcare provider.

“I’ve stopped taking Adalimumab (Amgevita 40mg fortnightly). Not discussed with medics/specialist nurses as feel they will express alarm and castigate me., whereas it’s a relatively informed decision and ultimately it’s about my body and my life. Typing this is making me think I probably should have discussed it with health team”

Finally, what was also evident throughout participant’s responses was disappointment at the UK Governments response and handling of the COVID-19 lockdown. Many participants reported that high concern about the UK Government’s response. For instance,

“The UK government was slow to act initially even though it had clear examples across Europe of how the pandemic would spread. I found its advice vague and optional. It has put the immediate economy ahead of lives. Cummings has destroyed the credibility of lockdown. I am angry at how this has all been handled.”

“Don’t feel the government acted quickly or strongly enough around lock down. The situation with airports is shocking.”

“Afraid, insecure, very anxious, stressed, verging on depression (i am prone to it and use HRT/CBT to balance it). I assume if I get COVID-19 then I will likely die. the fact we have an utterly incompetent government who are making things worse on purpose whilst they trial their ’herd immunity plan’ with no cure doesn’t help me feel that it the situation will get better any time soon. Given that I also have a heart condition, the stress from this isn’t helping.”

Within this theme, were reoccurring negative perceptions about the UK Government’s handling of the Dominic Cummings incident (Former Chief Advisor to the UK Prime Minister; [13]). Comments included:

“I feel that the lack of immediate response by the government, the mumbling, bumbling style of our prime minister and the disgraceful behaviour of Dominic Cummings have considerably increased my anxiety levels.”

“… the government has decided to distract us all from the Dominic Cummings fiasco by loosening lockdown by too much too soon” and that “steps to ease lockdown are being rushed to deflect attention from the Dominic Cummings story and not based on sound science. If only we lived in NZ.

“I felt very comfortable that things were under control until last weekend when the government let me down and indicated that the rules don’t need to be followed (thanks to Mr Cummings escapades). I now feel a lot less secure”.

“Dominic Cummings might have known the rules for exceptional circumstances but these were not publicised to the general public beyond STAY AT HOME. Thank you.”

Discussion

This study is the first to provide a comprehensive qualitative exploration of the lived experiences of people identified as at high risk of severe illness by the UK Government. The study provides insights into their awareness, attitudes and actions relating to healthcare, health-related behaviours and mental health during the first COVID-19 lockdown in the UK, and as such, provide rich information about the unintended consequences of the COVID-19 restrictions. The results from this qualitative analysis reinforce and extend the insights from our previously published study [4]. Specifically, this study provides in-depth data about the lived experience and perceptions of people identified as at high risk of severe illness from COVID-19 during the first lockdown. In doing so, contributes further to our understanding of the impact of COVID-19 on mental health and wellbeing, health-related behaviours and reduced access to healthcare. The reduced access to healthcare reported by participants in this study has been substantiated by official UK Government statistics, showing that during the first wave of the pandemic, hospital admissions, accident and emergency attendances and the number of GP consultations were all down on previous years [14]. As reported by some participants in the current study, the reduction in people with worsening health conditions were attributed to a desire to not contribute to the pressure on the healthcare service as well as concerns about becoming infected with COVID-19 [14]. The perceptions reported of wanting to avoid further pressurising the NHS reflect the consistent media messaging that the healthcare service was struggling to cope with the demand, and in some cases, may have led to missed or delayed treatment to manage acute and chronic health conditions.

This study demonstrated that people identified as high risk of severe illness elicited feelings of vulnerability, anxiety, and isolation, which in some led to feelings of stigmatisation and blame for the COVID-19 restrictions. As such service providers and the Government should consider the potential implications of future messaging relating to COVID-19 and indeed messaging relating to other public health topics, as well as how these unintended consequences can be minimised and avoided. Most participants in this study noticed other people behaving differently towards them, and alarmingly, over half of respondents also reported feeling stigmatised. As we transition during the pandemic, it is imperative that people who are at high risk are supported to re-participate in society given the greater restrictions they have experienced during the pandemic and can do so without bias or discrimination. For instance, a pertinent area to consider is the return to work given the importance of employment for health and wellbeing [15].

Furthermore, results showed that participants adhered to UK Government recommendations regarding social distancing, self-isolation and shielding. However, there was a sense of resentment to those not following the recommendations and not taking them seriously, while others felt that everyone should be playing their part in reducing risk. Previous research has reported that resistance to change is not uncommon where choices and aspects of freewill are required to take a sudden change of approach, reflecting the rapid changes that resulted from the decisions undertaken by the UK Government during the COVID-19 lockdown [16]. To overcome such resistance to change, it is important that social support networks are available [16]. The current study highlighted mostly positive comments regarding support and participants felt they had the necessary contact from family and friends which in turn, helped them engender a culture where they felt confident to make decisions and take actions. Further efforts could also be made by the UK Government to adopt a bottom-up approach to information dissemination, whereby a greater effort is made to voice the opinions of those at ground level [17].

Findings of particular concern was that participants reported reduced access to healthcare provision (across appointments, medication, elective surgery, communication platform, & clinician care) which resulted in them independently changing the management of their long-term health condition, potentially placing them at even greater risk. This, in turn, had a detrimental impact on mental health and wellbeing, supporting recent research examining the impact on people at high risk of COVID-19 infection [1820]. This highlights that services need to consider how they can support their patients during periods of reduced access, to ensure they feel supported and remain safe. This may involve self-management support strategies in primary care to upskill patients to manage their own conditions, these strategies have been shown to improve clinical indicators, self-efficacy and patient knowledge [21]. COVID-19 has challenged the way staff have been taught to deliver care, as roles and responsibilities have been redefined, new tools and processes implemented, and cross-professional/sectoral collaboration formalised [17]. This can often lead to resistance, resignation or disregard. Existing literature suggests that both trust-based (relationship dynamics) and control-based (organisational dynamics) governance mechanisms play a crucial role in partnership development [22]. There is widespread agreement that a bottom-up approach is required, whereby the purpose and benefits of the change should not only be understood and embraced by individuals and communities at ground level, but also coproduced with them [23]. Given the speed of transition needed during the first lockdown this was not possible. However, lessons learned from this study and others need adopting beyond the current pandemic to ensure competency for future lockdown situations among as significant a proportion of the population as possible.

The COVID-19 pandemic exacerbates the importance of a hidden form of social inequality, namely digital inequalities [24]. Digital services have great potential to improve population health and the efficiency and reach of basic needs and healthcare [25]. Mobile apps, text messages, wearable and ambient sensors, social media, and interactive websites can improve health by supporting behaviours involved in disease prevention, self-management of long-term conditions and delivery of evidence-based practice [25]. Such was reflected in the current study as the adoption of digital services appeared to be received positively by the majority of participants and expands on our understanding of how digital services have been received. Availability, ease of access and quality of support were the major benefits noted and were ubiquities across all high risk groups. The qualitative data did not seem to explain why women did not like digital services as much [4], and therefore this needs further exploration and whether this might impact on service uptake that have a higher prevalence of female patients. Although many participants were aware and often accepted that a transition to digital solutions was compulsory, concurrent with previous research [26], there was a preference to return to ‘normal’ face-to-face interactions as soon as possible. Hence, hybrid solutions that offer a blend of face-to-face and digital treatment tailored, as best as possible, to individual needs may be the most effective solution in the future. A focus on equity and ethics is warranted to ensure digital health truly increases access to impactful digital services. Indeed, it’s important to ensure that the provision of digital services does not worsen inequalities [27]. Engagement approaches that help individuals of all backgrounds be aware and understand the benefits of digital services including online campaigns, social media exposure, and radio advertising are warranted.

This change in the way healthcare is provided is likely to continue in the future and is in line with the NHS long-term plan for increased digital healthcare provision [28], with older participants being particularly keen on digital healthcare continuing [4]. This is in line with previous research showing that older participants (≥55 years of age) demonstrate considerable interest in learning how to use the internet for accessing services [29]. However, service providers’ ambitions to engage with older adults online appear more limited as a result of entrenched stereotypes of older non-users, a lack of internal digital skills, as well as organisational and funding constraints [29]. The current study’s findings emphasise the importance of balancing the views of older adults and service providers in the design of online engagement strategies. These insights are critical for improving online service delivery affected by an increasing withdrawal of traditional services. Further research is warranted in exploring the best methods to deliver training and support for digital services to enable as many individuals as possible access. Harnessing the surge in interest, enthusiasm, and acceptance of digital offers during lockdown situations has immediately been recognised as an opportunity for service providers [30]. Consequently, complementary qualitative evaluations are crucial to fully understand and interpret user experiences, as well as developing and evaluating user engagement and overall effectiveness.

The perceptions of people identified as high risk relating to the UK Government response, including the Dominic Cummings incident, is particularly pertinent given the guidance that specified greater restrictions on their daily life. Clearly, this incident led to a national outcry where some people believed that Cummings’ actions—that are akin to other lockdown guidance breaches and led to other officials leaving their posts—has both impacted people’s emotional response and raised questions of Government handling of the incident [31]. At a time when national action and strong leadership was required [32], breaches by the very proponents and perceived leaders of lockdown legislation may undermine its continued implementation and negatively affect people most impacted.

A strength of the study was the comprehensive assessment of qualitative survey data theoretically underpinned by the methodological framework for combining quantitative and qualitative survey methods [7]. The triangulation of data is a further strength which enhanced understanding of qualitative survey data and subsequently, overall awareness, attitudes and actions. Furthermore, this study addresses the limitation identified in previous research about only using polling data to understand public opinions regarding lockdown policies [33]. Study limitations are also noted and discussed in previous publications [4]. A pragmatic sub-sample of people identified as at high risk of severe illness from COVID-19 were recruited via convenience sampling methods and hence results cannot be considered generalisable. The subjective nature of the data is also a limitation, as is the presence of self-selection bias which resulted from the pragmatic sampling methods adopted.

Conclusion

The findings of this study provide novel insights about the lived experience of UK adults at high risk of severe illness during the first COVID-19 lockdown. In the context of digital service offers such as accessing basic needs and healthcare, the ubiquity of digital technologies and their adoption into day-to-day life translates into greater potential reach, and consequently greater potential for positive impact. However, the potential public health impact of these digital service offers can only be realised to the extent of their availability, accessibility, and efficacy. These rich findings sheds new light on the lived experiences of COVID-19 for UK adults identified as at high risk, which should be considered by policymakers, healthcare and charities and other organisations supporting people in these high risk groups both now, and through the recovery phase of the pandemic.

Supporting information

S1 File. Awareness, Attitudes and Actions (AAA) survey.

(DOCX)

S1 Dataset

(XLS)

Acknowledgments

We would like to acknowledge and thank the following organisations for disseminating the survey.

APPG Obesity

APPG Medical Research

Anticoagulation UK

Association for Medical Research Charities

Asthma UK

Blackpool, Fylde & Wyre haemochromatosis Support Group

British Dietetics Association

British Liver Trust

British Lung Foundation

Diabetes UK

Elton John AIDS Foundation

European Association for the Study of Obesity

Hepatitis C Trust

Kidney Care UK

JDRF

Leeds Academic Health Partnership

LIVErNORTH

Melanoma UK

MS Society

Nexus Leeds

Norfolk & Norwich Liver Group

Obesity UK

Parkinson’s Society

PBC Foundation

Public Health Scotland

Research for the Future

Salford Sickle Cell Society

Terrance Higgins Trust

The Somerville Foundation

Yorkshire Cancer Community

Data Availability

The datasets used in the current study cannot be shared publicly because they contain potentially sensitive and identifiable patient information.Data are available on request from the University of School of Psychology Research ethic committee University of Leeds for researchers who meet the criteria for access to confidential data (psyc-ethicssubmissions@leeds.ac.uk).

Funding Statement

This study was partly supported by an investigator-initiated grant from Ethicon, Johnson & Johnson to SWF; the funder had no role in study design, data analysis, data interpretation, or writing of the report (grant number: 202004001).

References

  • 1.Department of Health & Social Care & Public Health England. Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. 2021. [Cited 09 May 2021]. Available from: https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19
  • 2.Public Health England. (2020). Guidance on social distancing for everyone in the UK. 2020. [Cited 09 May 2021]. Available from: https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults
  • 3.Wolf MS, Serper M, Opsasnick L, O’Conor RM, Curtis L, Benavente JY et al. Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the US outbreak: a cross-sectional survey. Annals of internal medicine. 2020. Jul 21;173(2):100–9. doi: 10.7326/M20-1239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Flint SW, Brown A, Tahrani AA, Piotrkowicz A, Joseph AC. Cross-sectional analysis to explore the awareness, attitudes and actions of UK adults at high risk of severe illness from COVID-19. BMJ open. 2020. Dec 1;10(12):e045309. doi: 10.1136/bmjopen-2020-045309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sallis A, Porter L, Tan K, Howard R, Brown L, Jones A, et al. Improving child weight management uptake through enhanced National Child Measurement Programme parental feedback letters: A randomised controlled trial. Preventive medicine. 2019. Apr 1;121:128–35. doi: 10.1016/j.ypmed.2019.01.023 [DOI] [PubMed] [Google Scholar]
  • 6.French DP, Olander EK, Chisholm A, Mc Sharry J. Which behaviour change techniques are most effective at increasing older adults’ self-efficacy and physical activity behaviour? A systematic review. Annals of behavioral medicine. 2014. Oct 1;48(2):225–34. doi: 10.1007/s12160-014-9593-z [DOI] [PubMed] [Google Scholar]
  • 7.Marsland N, Wilson I, Abeyasekera S, Kleih U. A methodological framework for combining quantitative and qualitative survey methods. Draft best practice guideline submitted to DFID/NRSP socio-economic methodologies. 2000. [Google Scholar]
  • 8.Zahle J. Objective data sets in qualitative research. Synthese. 2020. Mar 25:1–7. [Google Scholar]
  • 9.Glasgow RE, Green LW, Taylor MV, Stange KC. An evidence integration triangle for aligning science with policy and practice. American journal of preventive medicine. 2012. Jun 1;42(6):646–54. doi: 10.1016/j.amepre.2012.02.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kremers SP. Theory and practice in the study of influences on energy balance-related behaviors. Patient education and counseling. 2010. Jun 1;79(3):291–8. doi: 10.1016/j.pec.2010.03.002 [DOI] [PubMed] [Google Scholar]
  • 11.Sanders GJ, Griffiths C, Flint S, Christensen A, Gately P. Implementation fidelity of an Integrated Healthy Lifestyle Service: a process evaluation. Perspectives in Public Health. 2021. Mar 29:1757913920986205. doi: 10.1177/1757913920986205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Aggio D, Fairclough S, Knowles Z, Graves L. Validity and reliability of a modified english version of the physical activity questionnaire for adolescents. Archives of Public Health. 2016. Dec;74(1):1–9. doi: 10.1186/s13690-016-0115-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fancourt D. et al. The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic The Lancet, 396; 10249; 464–465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Public Health England. What the health profile for England shows us about the wider impacts of COVID-19 on health. [Cited 15 Sept 2021]. Available from: What the Health Profile for England shows us about the wider impacts of COVID-19 on health—Public health matters (blog.gov.uk)
  • 15.Emerson E, Fortune N, Aitken Z, Hatton C, Stancliffe R, Llewellyn G. The wellbeing of working-age adults with and without disability in the UK: associations with age, gender, ethnicity, partnership status, educational attainment and employment status. Disability and health journal. 2020. Jul 1;13(3):100889. doi: 10.1016/j.dhjo.2020.100889 [DOI] [PubMed] [Google Scholar]
  • 16.Röth T, Spieth P. The influence of resistance to change on evaluating an innovation project’s innovativeness and risk: A sensemaking perspective. Journal of Business Research. 2019. Aug 1;101:83–92. [Google Scholar]
  • 17.Bussu S, Marshall M. Organisational development to support integrated care in East London: the perspective of clinicians and social workers on the ground. Journal of Health Organization and Management. 2020. May 19. doi: 10.1108/JHOM-10-2019-0294 [DOI] [PubMed] [Google Scholar]
  • 18.Brown A, Flint SW, Kalea AZ, O’Kane M, Williams S, Batterham RL. Negative impact of the first COVID-19 lockdown upon health-related behaviours and psychological wellbeing in people living with severe and complex obesity in the UK. EClinicalMedicine. 2021. Mar 18:100796. doi: 10.1016/j.eclinm.2021.100796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Singhal R, Tahrani AA, Sakran N, Herrera M, Menon V, Khaitan M, et al. Effect of COVID-19 Pandemic on Global Bariatric Surgery PRActiceS-The COBRAS study. Obesity Research & Clinical Practice. 2021. Apr 23. doi: 10.1016/j.orcp.2021.04.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chaix B, Delamon G, Guillemassé A, Brouard B, Bibault JE. Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations. Gen Psychiatr. 2020. Nov 26;33(6):e100349. doi: 10.1136/gpsych-2020-100349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dineen-Griffin S, Garcia-Cardenas V, Williams K, Benrimoj SI. Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice. PloS one. 2019. Aug 1;14(8):e0220116. doi: 10.1371/journal.pone.0220116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Valentijn PP, Vrijhoef HJ, Ruwaard D, de Bont A, Arends RY, Bruijnzeels MA. Exploring the success of an integrated primary care partnership: a longitudinal study of collaboration processes. BMC health services research. 2015. Dec;15(1):1–8. doi: 10.1186/s12913-014-0634-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Erlingsdottir G, Ersson A, Borell J, Rydenfält C. Driving for successful change processes in healthcare by putting staff at the wheel. Journal of health organization and management. 2018. Mar 19. [DOI] [PubMed] [Google Scholar]
  • 24.Beaunoyer E, Dupéré S, Guitton MJ. COVID-19 and digital inequalities: Reciprocal impacts and mitigation strategies. Computers in human behavior. 2020. Oct 1;111:106424. doi: 10.1016/j.chb.2020.106424 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Michie S, Yardley L, West R, Patrick K, Greaves F. Developing and evaluating digital interventions to promote behavior change in health and health care: recommendations resulting from an international workshop. Journal of medical Internet research. 2017;19(6):e232. doi: 10.2196/jmir.7126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Torous J, Myrick KJ, Rauseo-Ricupero N, Firth J. Digital mental health and COVID-19: using technology today to accelerate the curve on access and quality tomorrow. JMIR mental health. 2020;7(3):e18848. doi: 10.2196/18848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Abbott S, Parretti HM, Hazlehurst J, Tahrani AA. Socio‐demographic predictors of uptake of a virtual group weight management program during the COVID‐19 pandemic. Journal of Human Nutrition and Dietetics. 2020. Dec 23. doi: 10.1111/jhn.12850 [DOI] [PubMed] [Google Scholar]
  • 28.NHS England. The NHS Long Term Plan. NHS England, UK. 2019. [Cited 09 May 2021]. Available from: https://www.longtermplan.nhs.uk/
  • 29.Hodge H, Carson D, Carson D, Newman L, Garrett J. Using Internet technologies in rural communities to access services: The views of older people and service providers. Journal of Rural Studies. 2017. Aug 1;54:469–78. [Google Scholar]
  • 30.Wind TR, Rijkeboer M, Andersson G, Riper H. The COVID-19 pandemic: The ‘black swan’ for mental health care and a turning point for e-health. Internet interventions. 2020. Apr;20. doi: 10.1016/j.invent.2020.100317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Fancourt D, Steptoe A, Wright L. The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic. The Lancet. 2020. Aug 15;396(10249):464–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bonell C, Michie S, Reicher S, West R, Bear L, Yardley L, et al. Harnessing behavioural science in public health campaigns to maintain ‘social distancing’ in response to the COVID-19 pandemic: key principles. J Epidemiol Community Health. 2020. May 8. doi: 10.1136/jech-2020-214290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Foad CMG, Whitmarsh L, Hanel PHP, Haddock G. The limitations of polling data in understanding public support for COVID-19 lockdown policies. R Soc Open Sci. 2021. Jul 7;8(7):210678. doi: 10.1098/rsos.210678 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Christophe Leroyer

10 Aug 2021

PONE-D-21-15375

Exploring the awareness, attitudes, and actions (AAA) of UK adults at high risk of severe illness from COVID-19

PLOS ONE

Dear Dr. Brown,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by September 30th. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Christophe Leroyer

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This study was partly supported by an investigator-initiated grant from Ethicon, J&J; the funder had no role in study design, data analysis, data interpretation, or writing of the report.”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 “This study was partly supported by an investigator-initiated grant from Ethicon, J&J to SWF; the funder had no role in study design, data analysis, data interpretation, or writing of the report.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

6. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

7. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works, some of which you are an author.

https://bmjopen.bmj.com/content/10/12/e045309.info

We would like to make you aware that copying extracts from previous publications, especially outside the methods section, word-for-word is unacceptable. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications.

Please revise the manuscript to rephrase the duplicated text, cite your sources, and provide details as to how the current manuscript advances on previous work. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work.

We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: My answer is generally very favorable, but one point needs clarification. The author repeatedly associates "mental health" and "well-being". So there seems to be a closeness between the two terms as well as a difference. Could he be more specific?

Reviewer #2: Dear Authors,

Thanks for submitting your article to PlosOne. Thank you for giving me the opportunity to read your very interesting work.

The subject of this article is impact of COVID-19 lockdown in a high risk of severe illness UK patients. It is a relevant subject. Authors used a specific questionnaire described in a previous article (BMJ Open 2020). This is a qualitative study on answers from this survey. Methods are relevant. Few data on this field have been published. Tables and results are well described. The article is well structured.

Aims of the study are clearly written in introduction and answers well described in discussion and conclusion

English language is good.

Minor revisions:

In Introduction p 4 l76-78: introduction or methods. I think it is relevant to have a specific sentence on your definition of the term impact in methods.

Table 1: in the part attitudes and concerns and also self-isolation be careful on tabulation

Defined +ve and – ve in legend

P 13 l 261 put a ref (maybe not scientific) on Dominic Cumming’s incident or explain it in some words for non UK readers…

Discussion:

Shortened the discussion

Some ref could be added as:

Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations.

Chaix B, Delamon G, Guillemassé A, Brouard B, Bibault JE. Gen Psychiatr. 2020 Nov 26;33(6):e100349. doi: 10.1136/gpsych-2020-100349. eCollection 2020.

PMID: 34192239 Free PMC article.

The limitations of polling data in understanding public support for COVID-19 lockdown policies.

Foad CMG, Whitmarsh L, Hanel PHP, Haddock G. R Soc Open Sci. 2021 Jul 7;8(7):210678. doi: 10.1098/rsos.210678. eCollection 2021 Jul.

PMID: 34258021 Free PMC article.

1. Understanding the psychological impact of the COVID-19 pandemic and containment measures: An empirical model of stress.

Wissmath B, Mast FW, Kraus F, Weibel D.

PLoS One. 2021 Jul 29;16(7):e0254883. doi: 10.1371/journal.pone.0254883. eCollection 2021.

PMID: 34324498 Free PMC article.

2. Impact of COVID-19-like symptoms on occurrence of anxiety/depression during lockdown among the French general population.

Mary-Krause M, Herranz Bustamante JJ, Héron M, Andersen AJ, El Aarbaoui T, Melchior M.

PLoS One. 2021 Jul 26;16(7):e0255158. doi: 10.1371/journal.pone.0255158. eCollection 2021.

PMID: 34310661 Free PMC article.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Anne-Hélène Le Cornec Ubertini, Senior Lecturer in Information and Communication Sciences

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: plos one rev UK AAA covid 19 2021.docx

PLoS One. 2021 Nov 11;16(11):e0259376. doi: 10.1371/journal.pone.0259376.r002

Author response to Decision Letter 0


5 Oct 2021

Thank you very much for the editors and reviewers useful comments which we have addressed them below. Please find our responses in bold.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Thank you for your comment we have reviewed the PLOS ONE style requirements and amended accordingly.

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

Thank you for the comment this has been added to the Funding information section as requested as follows:

“This study was partly supported by an investigator-initiated grant from Ethicon, Johnson & Johnson to SWF; the funder had no role in study design, data analysis, data interpretation, or writing of the report (grant number: 202004001)”

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This study was partly supported by an investigator-initiated grant from Ethicon, J&J; the funder had no role in study design, data analysis, data interpretation, or writing of the report.”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“This study was partly supported by an investigator-initiated grant from Ethicon, J&J to SWF; the funder had no role in study design, data analysis, data interpretation, or writing of the report.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

This has been removed from the main text and has been added to the reply letter as follows:

“This study was partly supported by an investigator-initiated grant from Ethicon, Johnson & Johnson to SWF; the funder had no role in study design, data analysis, data interpretation, or writing of the report (grant number: 202004001)”

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Thank you for your comment. We have added the study minimal data set to the resubmission find attached. The qualitative data within the study offers in some instances personal and sensitive experiences during COVID-19 e.g., about personal clinical experiences with clinician and about medical conditions, which could result in people being identified. But can be made available for researchers who meet the criteria for access to confidential data on request to the School of Psychology Research ethic committee University of Leeds

We have changed the data sharing statement as recommended to the following:

"The datasets used in the current study cannot be shared publicly because they contain potentially sensitive and identifiable patient information. Data are available on request from the University of School of Psychology Research ethic committee University of Leeds for researchers who meet the criteria for access to confidential data (psyc-ethicssubmissions@leeds.ac.uk)"

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

As above, we have added the study minimal data set to the resubmission find attached.

6. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

Dr Adrian Brown is affiliated with the University College London and should be the corresponding author. There was no place within the revision section of journal platform to confirm this. But have indicated on the manuscript that Dr Brown is the corresponding author and submitted the manuscript.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Thank you for your comment. We have checked the referencing and added further references in response to changes to the reviewers comments.

7. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works, some of which you are an author.

https://bmjopen.bmj.com/content/10/12/e045309.info

We would like to make you aware that copying extracts from previous publications, especially outside the methods section, word-for-word is unacceptable. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications.

Please revise the manuscript to rephrase the duplicated text, cite your sources, and provide details as to how the current manuscript advances on previous work. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work.

We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough.

Thank you for your feedback and for noting that these sections needed to be addressed in particular in the introduction and methods. We have significantly revised the text to avoid any overlap with the previous publication, please see update manuscript.

1. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fjournals.plos.org%2Fplosone%2Fs%2Fsupporting-information&data=04%7C01%7Ca.c.brown%40ucl.ac.uk%7C35cc163fee454a82452408d981f1e66a%7C1faf88fea9984c5b93c9210a11d9a5c2%7C0%7C0%7C637683698214095605%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=%2Bo0eMgfOiavaUpH47CermovLzFfv5Y5m5VUoayEKL3I%3D&reserved=0.

Thank you for the comment. We have now included a caption at the end of the manuscript for the supplementary materials called: S1 Supplementary Information: Awareness, Attitudes and Actions (AAA) survey. This is identified within the text where needed.

Reviewer 1:

We thank this Reviewer for their helpful comments regarding our manuscript and we have addressed each point below.

My answer is generally very favorable, but one point needs clarification. The author repeatedly associates "mental health" and "well-being". So there seems to be a closeness between the two terms as well as a difference. Could he be more specific?

Thank you for your useful and insightful comment. Mental health and wellbeing are interrelated terms. Mental health is defined as “a positive concept related to the social and emotional wellbeing of individuals and communities”. Wellbeing can be wider to include physical, social as well as psychological wellbeing. Therefore we have used the term “mental health and wellbeing” to be inclusive of both concepts.

Reviewer 2:

We thank this Reviewer for their helpful comments regarding our manuscript and we have addressed each point below.

Dear Authors,

Thanks for submitting your article to PlosOne. Thank you for giving me the opportunity to read your very interesting work.

The subject of this article is impact of COVID-19 lockdown in a high risk of severe illness UK patients. It is a relevant subject. Authors used a specific questionnaire described in a previous article (BMJ Open 2020). This is a qualitative study on answers from this survey. Methods are relevant. Few data on this field have been published. Tables and results are well described. The article is well structured.

Aims of the study are clearly written in introduction and answers well described in discussion and conclusion

English language is good.

Minor revisions:

In Introduction p 4 l76-78: introduction or methods. I think it is relevant to have a specific sentence on your definition of the term impact in methods.

Thank you for your comment we have moved the sentence within the introduction to the methods and clarified how we are defining impact.

Table 1: in the part attitudes and concerns and also self-isolation be careful on tabulation

Thank you for the comment we have reviewed the table and the column and rows appear to be appropriately formatted. But we have add addition lines to help

Defined +ve and – ve in legend

Thank you we have added in this to the note page line

P 13 l 261 put a ref (maybe not scientific) on Dominic Cumming’s incident or explain it in some words for non UK readers…

Thank you for your comment we have clarified who Dominic Cumming was and also referenced a correspondence published in the Lancet on the incident.

Discussion:

Shortened the discussion

Thank you for your comment. We have reviewed the discussion and shortened the discussion. Please see revised manuscript.

Some ref could be added as:

Thank you for your recommendation for adding references we have reviewed them and added two of the suggested recommendations that were appropriate.

Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations.

Chaix B, Delamon G, Guillemassé A, Brouard B, Bibault JE. Gen Psychiatr. 2020 Nov 26;33(6):e100349. doi: 10.1136/gpsych-2020-100349. eCollection 2020.

The limitations of polling data in understanding public support for COVID-19 lockdown policies.

Foad CMG, Whitmarsh L, Hanel PHP, Haddock G. R Soc Open Sci. 2021 Jul 7;8(7):210678. doi: 10.1098/rsos.210678. eCollection 2021 Jul.

Attachment

Submitted filename: Response to reviewers_comments_PLOS ONE.docx

Decision Letter 1

Christophe Leroyer

19 Oct 2021

Exploring the awareness, attitudes, and actions (AAA) of UK adults at high risk of severe illness from COVID-19

PONE-D-21-15375R1

Dear Dr. Brown,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Christophe Leroyer

Academic Editor

PLOS ONE

Acceptance letter

Christophe Leroyer

26 Oct 2021

PONE-D-21-15375R1

Exploring the awareness, attitudes, and actions (AAA) of UK adults at high risk of severe illness from COVID-19

Dear Dr. Brown:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Christophe Leroyer

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Awareness, Attitudes and Actions (AAA) survey.

    (DOCX)

    S1 Dataset

    (XLS)

    Attachment

    Submitted filename: plos one rev UK AAA covid 19 2021.docx

    Attachment

    Submitted filename: Response to reviewers_comments_PLOS ONE.docx

    Data Availability Statement

    The datasets used in the current study cannot be shared publicly because they contain potentially sensitive and identifiable patient information.Data are available on request from the University of School of Psychology Research ethic committee University of Leeds for researchers who meet the criteria for access to confidential data (psyc-ethicssubmissions@leeds.ac.uk).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES